Infliximab efficacy in rheumatoid arthritis after an inadequate response to etanercept or adalimumab: results of a target-driven active switch study. [electronic resource]
Producer: 20150528Description: 2139-49 p. digitalISSN:- 1473-4877
- Adalimumab
- Adult
- Aged
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antirheumatic Agents -- therapeutic use
- Arthritis, Rheumatoid -- drug therapy
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug Substitution
- Etanercept
- Female
- Humans
- Immunoglobulin G -- therapeutic use
- Infliximab
- Male
- Methotrexate -- therapeutic use
- Middle Aged
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Single-Blind Method
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.